feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Type of Medium
Language
Region
Years
Person/Organisation
Subjects(RVK)
Access
  • 1
    Online Resource
    Online Resource
    Basel :Karger,
    UID:
    edoccha_BV036069211
    Format: 1 Online-Ressource (IX, 166 Seiten) : , Illustrationen, Diagramme.
    ISBN: 978-3-318-00255-3
    Series Statement: Monographs in clinical neuroscience Vol. 16
    Content: Stroke is the third leading cause of death in industrialized countries and the number one cause of disability in adults. Ischemic strokes constitute approximately 80% of all strokes, and until recently, no effective therapies had been available. The successful tissue plasminogen activator (tPA) trials open a new era of stroke management with a proven therapeutic now available to patients if they arrive at the hospital within hours of the onset of symptoms. Recent advances in our understanding of the molecular mechanisms of ischemic brain injury and vascular pathology have opened up new avenues for the development of novel therapeutic strategies. The premise that substantial reduction of brain damage after ischemic stroke by therapeutic intervention has now been confirmed in animal stroke models, sets a realistic goal for future treatment of stroke patients. This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most current views on the clinical stroke trials and academic and industrial efforts to develop new drugs.The authors are leading authorities in their own fields in basic and clinical stroke research. As a timely and comprehensive volume, it will be of immense value to basic and clinical investigators, neurologists and neurosurgeons who manage stroke patients, neuroscientists interested in various aspects of brain injury, and researchers in the pharmaceutical industry who are engaged in new drug development
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-6560-8
    Language: English
    Subjects: Medicine
    RVK:
    Keywords: Hirnkrankheit ; Ischämie ; Schlaganfall ; Aufsatzsammlung
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Basel : Karger
    UID:
    b3kat_BV036069211
    Format: 1 Online-Ressource (IX, 166 Seiten) , Illustrationen, Diagramme
    ISBN: 9783318002553
    Series Statement: Monographs in clinical neuroscience Vol. 16
    Content: Stroke is the third leading cause of death in industrialized countries and the number one cause of disability in adults. Ischemic strokes constitute approximately 80% of all strokes, and until recently, no effective therapies had been available. The successful tissue plasminogen activator (tPA) trials open a new era of stroke management with a proven therapeutic now available to patients if they arrive at the hospital within hours of the onset of symptoms. Recent advances in our understanding of the molecular mechanisms of ischemic brain injury and vascular pathology have opened up new avenues for the development of novel therapeutic strategies. The premise that substantial reduction of brain damage after ischemic stroke by therapeutic intervention has now been confirmed in animal stroke models, sets a realistic goal for future treatment of stroke patients. This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most current views on the clinical stroke trials and academic and industrial efforts to develop new drugs.The authors are leading authorities in their own fields in basic and clinical stroke research. As a timely and comprehensive volume, it will be of immense value to basic and clinical investigators, neurologists and neurosurgeons who manage stroke patients, neuroscientists interested in various aspects of brain injury, and researchers in the pharmaceutical industry who are engaged in new drug development
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-6560-8
    Language: English
    Subjects: Medicine
    RVK:
    Keywords: Hirnkrankheit ; Ischämie ; Schlaganfall ; Aufsatzsammlung
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Basel : S. Karger
    UID:
    gbv_1672336201
    Format: Online-Ressource
    Edition: Karger eBooks Collection 1997-2009
    ISBN: 9783318002553
    Series Statement: Monographs in clinical neuroscience 16
    Content: Stroke is the third leading cause of death in industrialized countries and the number one cause of disability in adults. Ischemic strokes constitute approximately 80% of all strokes, and until recently, no effective therapies had been available. The successful tissue plasminogen activator (tPA) trials open a new era of stroke management with a proven therapeutic now available to patients if they arrive at the hospital within hours of the onset of symptoms. Recent advances in our understanding of the molecular mechanisms of ischemic brain injury and vascular pathology have opened up new avenues for the development of novel therapeutic strategies. The premise that substantial reduction of brain damage after ischemic stroke by therapeutic intervention has now been confirmed in animal stroke models, sets a realistic goal for future treatment of stroke patients. This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most current views on the clinical stroke trials and academic and industrial efforts to develop new drugs.The authors are leading authorities in their own fields in basic and clinical stroke research. As a timely and comprehensive volume, it will be of immense value to basic and clinical investigators, neurologists and neurosurgeons who manage stroke patients, neuroscientists interested in various aspects of brain injury, and researchers in the pharmaceutical industry who are engaged in new drug development
    Note: Includes bibliographical references and indexes , ""Contents""; ""Preface""; ""Mechanisms of Ischemic Brain Injury Amenable to Therapeutic Interventions""; ""Glutamate Receptor-Mediated Neuronal Death in the Ischemic Brain1""; ""Oxygen Radical Mechanisms in Cerebral Ischemia and Reperfusion""; ""Nitric Oxide in Cerebrovascular Regulation and Ischemia""; ""Inflammatory Response and Adhesion Molecules in Focal Cerebral Ischemia""; ""Temperature Influences on Ischemic Brain Injury1""; ""Apoptosis""; ""Neurotrophic Factors""; ""New Drug Development""; ""Current Status of New Drug Development for Ischemic Stroke"" , ""New Magnetic Resonance Imaging Techniques for Stroke Diagnosis and Treatment""""Future Directions in Research and Development of New Treatments for Ischemic Stroke""; ""Author Index Subject Index""
    Additional Edition: ISBN 9783805565608
    Language: English
    Subjects: Medicine
    RVK:
    Keywords: Hirnkrankheit ; Ischämie ; Schlaganfall
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Online Resource
    Online Resource
    Basel ; : Karger,
    UID:
    almafu_9958103969602883
    Format: 1 online resource (176 p.)
    ISBN: 3-318-00255-0
    Series Statement: Monographs in clinical neuroscience ; vol. 16
    Content: Stroke is the third leading cause of death in industrialized countries and the number one cause of disability in adults. Ischemic strokes constitute approximately 80% of all strokes, and until recently, no effective therapies had been available. The successful tissue plasminogen activator (tPA) trials open a new era of stroke management with a proven therapeutic now available to patients if they arrive at the hospital within hours of the onset of symptoms. Recent advances in our understanding of the molecular mechanisms of ischemic brain injury and vascular pathology have opened up new avenues for the development of novel therapeutic strategies. The premise that substantial reduction of brain damage after ischemic stroke by therapeutic intervention has now been confirmed in animal stroke models, sets a realistic goal for future treatment of stroke patients. This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most current views on the clinical stroke trials and academic and industrial efforts to develop new drugs. The authors are leading authorities in their own fields in basic and clinical stroke research. As a timely and comprehensive volume, it will be of immense value to basic and clinical investigators, neurologists and neurosurgeons who manage stroke patients, neuroscientists interested in various aspects of brain injury, and researchers in the pharmaceutical industry who are engaged in new drug development.
    Note: Description based upon print version of record. , ""Contents""; ""Preface""; ""Mechanisms of Ischemic Brain Injury Amenable to Therapeutic Interventions""; ""Glutamate Receptor-Mediated Neuronal Death in the Ischemic Brain1""; ""Oxygen Radical Mechanisms in Cerebral Ischemia and Reperfusion""; ""Nitric Oxide in Cerebrovascular Regulation and Ischemia""; ""Inflammatory Response and Adhesion Molecules in Focal Cerebral Ischemia""; ""Temperature Influences on Ischemic Brain Injury1""; ""Apoptosis""; ""Neurotrophic Factors""; ""New Drug Development""; ""Current Status of New Drug Development for Ischemic Stroke"" , ""New Magnetic Resonance Imaging Techniques for Stroke Diagnosis and Treatment""""Future Directions in Research and Development of New Treatments for Ischemic Stroke""; ""Author Index Subject Index"" , English
    Additional Edition: ISBN 3-8055-6560-7
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Basel :Karger,
    UID:
    almahu_BV036069211
    Format: 1 Online-Ressource (IX, 166 Seiten) : , Illustrationen, Diagramme.
    ISBN: 978-3-318-00255-3
    Series Statement: Monographs in clinical neuroscience Vol. 16
    Content: Stroke is the third leading cause of death in industrialized countries and the number one cause of disability in adults. Ischemic strokes constitute approximately 80% of all strokes, and until recently, no effective therapies had been available. The successful tissue plasminogen activator (tPA) trials open a new era of stroke management with a proven therapeutic now available to patients if they arrive at the hospital within hours of the onset of symptoms. Recent advances in our understanding of the molecular mechanisms of ischemic brain injury and vascular pathology have opened up new avenues for the development of novel therapeutic strategies. The premise that substantial reduction of brain damage after ischemic stroke by therapeutic intervention has now been confirmed in animal stroke models, sets a realistic goal for future treatment of stroke patients. This book covers topics ranging from fundamental molecular mechanisms of ischemic brain injury to the most current views on the clinical stroke trials and academic and industrial efforts to develop new drugs.The authors are leading authorities in their own fields in basic and clinical stroke research. As a timely and comprehensive volume, it will be of immense value to basic and clinical investigators, neurologists and neurosurgeons who manage stroke patients, neuroscientists interested in various aspects of brain injury, and researchers in the pharmaceutical industry who are engaged in new drug development
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-8055-6560-8
    Language: English
    Subjects: Medicine
    RVK:
    Keywords: Hirnkrankheit ; Ischämie ; Schlaganfall ; Aufsatzsammlung ; Aufsatzsammlung
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages